feed,title,long_url,short_url
Benzinga,Arvinas Highlights New ARV-110 Data In Prostate Cancer Patients,https://benzinga.com/general/biotech/22/02/25636474/arvinas-highlights-new-arv-110-data-in-prostate-cancer-patients,https://bit.ly/34E3u6S
Benzinga,Cerevel's Acute Anxiety Candidate Shows Encouraging Action In Healthy Volunteers,https://benzinga.com/general/biotech/22/02/25638059/cerevels-acute-anxiety-candidate-shows-encouraging-action-in-healthy-volunteers,https://bit.ly/3H4Inb3
Benzinga,ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting,https://benzinga.com/general/biotech/22/02/25635925/immunitybios-ankitva-shows-100-survival-at-two-years-in-bladder-cancer-setting,https://bit.ly/3Lzfp6l
